XML 33 R17.htm IDEA: XBRL DOCUMENT v3.23.3
Biological assets
12 Months Ended
Jun. 30, 2023
Biological assets  
Biological assets

14. Biological assets

 

Changes in the Group’s biological assets and their allocation to the fair value hierarchy for the years ended June 30, 2023 and 2022 were as follows:

 

 

 

Agricultural business

 

 

 

Sown land-crops

 

 

Sugarcane fields

 

 

Breeding cattle and cattle for sale (i)

 

 

Other

cattle (i)

 

 

Others

 

 

Total

 

 

 

Level 1

 

 

Level 3

 

 

Level 3

 

 

Level 2

 

 

Level 2

 

 

Level 1

 

 

Level 1

 

Balance as of June 30, 2021

 

 

326

 

 

 

13,370

 

 

 

8,215

 

 

 

12,943

 

 

 

217

 

 

 

156

 

 

 

35,227

 

Non-current (Production)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

11,126

 

 

 

200

 

 

 

156

 

 

 

11,482

 

Current (Consumable)

 

 

326

 

 

 

13,370

 

 

 

8,215

 

 

 

1,817

 

 

 

17

 

 

 

-

 

 

 

23,745

 

Balance as of June 30, 2021

 

 

326

 

 

 

13,370

 

 

 

8,215

 

 

 

12,943

 

 

 

217

 

 

 

156

 

 

 

35,227

 

Transfers

 

 

(1,000)

 

 

1,000

 

 

 

-

 

 

 

-

 

 

 

 

 

 

-

 

 

 

-

 

Purchases

 

 

-

 

 

 

-

 

 

 

-

 

 

 

3,738

 

 

 

11

 

 

 

-

 

 

 

3,749

 

Initial recognition and changes in the fair value of biological assets (i)

 

 

-

 

 

 

26,644

 

 

 

13,551

 

 

 

(647)

 

 

50

 

 

 

-

 

 

 

39,598

 

Decrease due to harvest

 

 

-

 

 

 

(77,180)

 

 

(23,276)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(100,456)

Sales

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(6,644)

 

 

(22)

 

 

-

 

 

 

(6,666)

Consumptions

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(30)

 

 

-

 

 

 

(26)

 

 

(56)

Costs for the year

 

 

5,668

 

 

 

42,047

 

 

 

12,754

 

 

 

5,797

 

 

 

-

 

 

 

6

 

 

 

66,272

 

Foreign exchange

 

 

(1,000)

 

 

(373)

 

 

(2,386)

 

 

(964)

 

 

-

 

 

 

-

 

 

 

(4,723)

Balance as of June 30, 2022

 

 

3,994

 

 

 

5,508

 

 

 

8,858

 

 

 

14,193

 

 

 

256

 

 

 

136

 

 

 

32,945

 

Non-current (Production)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

12,718

 

 

 

232

 

 

 

136

 

 

 

13,086

 

Current (Consumable)

 

 

3,994

 

 

 

5,508

 

 

 

8,858

 

 

 

1,475

 

 

 

24

 

 

 

-

 

 

 

19,859

 

Balance as of June 30, 2022

 

 

3,994

 

 

 

5,508

 

 

 

8,858

 

 

 

14,193

 

 

 

256

 

 

 

136

 

 

 

32,945

 

Purchases

 

 

-

 

 

 

-

 

 

 

-

 

 

 

1,156

 

 

 

12

 

 

 

-

 

 

 

1,168

 

Transfers

 

 

(835)

 

 

835

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Initial recognition and changes in the fair value of biological assets (i)

 

 

-

 

 

 

4,517

 

 

 

(375)

 

 

(5,397)

 

 

(92)

 

 

-

 

 

 

(1,347)

Decrease due to harvest

 

 

-

 

 

 

(56,662)

 

 

(13,703)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(70,365)

Sales

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(4,572)

 

 

(7)

 

 

-

 

 

 

(4,579)

Consumes

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(23)

 

 

(1)

 

 

(32)

 

 

(56)

Costs for the year

 

 

4,322

 

 

 

48,294

 

 

 

11,165

 

 

 

5,351

 

 

 

-

 

 

 

11

 

 

 

69,143

 

Currency translation adjustment

 

 

1,414

 

 

 

(757)

 

 

321

 

 

 

112

 

 

 

-

 

 

 

-

 

 

 

1,090

 

Balance as of June 30, 2023

 

 

8,895

 

 

 

1,735

 

 

 

6,266

 

 

 

10,820

 

 

 

168

 

 

 

115

 

 

 

27,999

 

Non-current (Production)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

9,044

 

 

 

147

 

 

 

114

 

 

 

9,305

 

Current (Consumable)

 

 

8,895

 

 

 

1,735

 

 

 

6,266

 

 

 

1,776

 

 

 

21

 

 

 

1

 

 

 

18,694

 

Balance as of June 30, 2023

 

 

8,895

 

 

 

1,735

 

 

 

6,266

 

 

 

10,820

 

 

 

168

 

 

 

115

 

 

 

27,999

 

 

(i)

Biological assets with a production cycle of more than one year (that is, cattle) generated “Initial recognition and changes in fair value of biological assets” amounting to ARS (5,489) and ARS (597) for the fiscal years ended June 30, 2023 and 2022, respectively. For the fiscal years ended June 30, 2023 and 2022, amounts of (ARS 3,416) and ARS 576, was attributable to price changes, and amounts of ARS (2,073) and ARS (1,173), was attributable to physical changes generated by production result, respectively.

Crops and oilseeds

 

The Group’s crops generally include crops and oilseeds (corn, wheat, soybean and sunflower) as well as peanut. The Group measures biological assets that have attained significant biological growth at fair value less costs to sell. The Group measures biological assets that have not attained significant biological growth or when the impact of biological transformation on price is not expected to be material, at cost less any impairment losses, which approximates fair value.

 

Sugarcane

 

The Group’s sugarcane production is based in Brazil and to a lesser extent in Bolivia. This crop’s production requires specific weather conditions (tropical and subtropical climates. The Group recognizes these crops at a fair value net of costs of sales from the moment of planting.

 

Fair value of biological assets

 

When an active market exists for biological assets, the Group uses the quoted market price in the principal market as a basis to determine the fair value of its biological assets. Live cattle is measured at fair value less cost to sell, based on market quoted at an auction involving cattle of the same age, breed and genetic merit adjusted, if applicable, to reflect any difference. When there is no active market or market-determined prices are not available, (for example, unharvested crops with significant growth or growing agricultural produce of sugarcane), the Group determines the fair value of a biological asset based on discounted cash flows models.

 

These models require the input of highly subjective assumptions including observable and unobservable data. The not observable information is determined based on the best information available for example, by reference to historical information of past practices and results, statistics and agricultural information and other analytical techniques. Key assumptions utilized in this method include future market prices, estimated yields at the point of harvest and estimated future costs of harvesting and other costs.

 

Market prices are generally determined by reference to observable data in the principal market for the agricultural produce. Harvesting costs and other costs are estimated based on historical and statistical data. Yields are estimated based on several factors including the location of the farmland and soil type, environmental conditions, infrastructure and other restrictions and growth at the time of measurement. Yields are subject to a high degree of uncertainty and may be affected by several factors out of the Group’s control including but not limited to extreme or unusual weather conditions, plagues and other crop diseases.

 

The key assumptions discussed above are highly sensitive. Reasonable shifts in assumptions including but not limited to increases or decreases in prices, costs and discount factors used may result in a significant increase or decrease to the fair value of biological assets recognized at any given time. Cash flows are projected based on estimated production. Estimates of production in themselves are dependent on various assumptions, in addition to those described above, including but not limited to several factors such as location, environmental conditions and other restrictions. Changes in these estimates could materially impact on estimated production, and could therefore affect estimates of future cash flows used in the assessment of fair value. The valuation models and their assumptions are reviewed periodically, and, if necessary, adjusted.

 

As of June 30 of each year, the Group’s biological assets that are subject to a valuation model include unharvested crops and sugarcane plantations.

 

The fair value less estimated selling costs of agricultural produce at the point of harvest amount to ARS 70,365 and ARS 100,456 for the years ended June 30, 2023 and 2022, respectively.

When no quoted prices are available in an active market, the Group uses a range of valuation models. The following table presents main parameters:

 

Description

Valuation technique

 Parameters

 Range 

Cattle (Level 2)

Comparable market prices

Price per livestock head/kg and per category

-

Sown land-crops  (Level 3)

Discounted cash flows

Yields - Operating costs - Selling expenses - Future of sale prices

Argentina

Yields: 0.77 - 10.50 tn./ha.

Future of sale prices:  51,921 - 124,611 ARS/tn

Operating cost: 5,153 -92,749 ARS/ha

Brazil:

Yields: 101.60 tn./ha.

Future of sale prices: 43.84  BRL/tn.

Operating cost: 11.45 BRL/ha.

Sugarcane fields (Level 3)

Discounted cash flows

Yields - Operating costs - Selling expenses - Future of sale prices - Discount rate

Brazil:

Yields: 83.43 tn/ha

Future of sale prices: 147.33 BRL/tn.

Operating cost: 85.58 BRL/tn.

 

As of June 30, 2023 and 2022, the better and maximum use of biological assets shall not significantly differ from the current use.

 

Capitalized cost of production as of June 30, 2023, 2022 and 2021 are as follows:

 

 

 

 06.30.2023

 

 

 06.30.2022

 

 

 06.30.2021

 

 

 

 

 

 

 

 

 

 

 

Supplies and labors

 

 

51,910

 

 

 

50,635

 

 

 

51,317

 

Salaries, social security costs and other personnel expenses

 

 

3,110

 

 

 

2,852

 

 

 

2,951

 

Depreciation and amortization

 

 

9,144

 

 

 

7,657

 

 

 

9,259

 

Fees and payments for services

 

 

137

 

 

 

170

 

 

 

172

 

Maintenance, security, cleaning, repairs and others

 

 

438

 

 

 

493

 

 

 

576

 

Taxes, rates and contributions

 

 

94

 

 

 

162

 

 

 

216

 

Leases and service charges

 

 

34

 

 

 

26

 

 

 

43

 

Freights

 

 

478

 

 

 

360

 

 

 

407

 

Travelling, library expenses and stationery

 

 

354

 

 

 

317

 

 

 

254

 

Other expenses

 

 

3,433

 

 

 

3,600

 

 

 

3,352

 

 

 

 

69,132

 

 

 

66,272

 

 

 

68,547